Efficacy and safety of ophthalmic epinastine evaluated using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis

被引：0
|
作者：
Schiffman, RM
Abelson, MB
Crampton, HJ
Slugg, AP
Michaelson, C
Bradford, RR
Kim, B
Lue, JC
Whitcup, SM
机构：
[1] Allergan Pharmaceut Inc, Irvine, CA USA
[2] Schepens Eye Res Inst, Boston, MA USA
[3] Ophthalm Res Associates, N Andover, MA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2002年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
107
引用
收藏
页码：U17 / U17
页数：1
相关论文
共 50 条
  • [31] THE EFFICACY OF A NEW ANTIALLERGIC AGENT, PENTYDE, IN THE ALLERGEN CHALLENGE MODEL OF ALLERGIC CONJUNCTIVITIS
    ABELSON, MB
    SMITH, LM
    GEORGE, MA
    THAYER, TO
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 683 - 683
  • [32] A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge model
    Berdy, GJ
    Spangler, DL
    Bensch, G
    Berdy, SS
    Brusatti, RC
    CLINICAL THERAPEUTICS, 2000, 22 (07) : 826 - 833
  • [33] POOLED ANALYSIS OF 2 CONFIRMATORY TRIALS EVALUATING THE EFFICACY AND SAFETY OF OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION 0.77% USING A CONJUNCTIVAL ALLERGEN CHALLENGE MODEL
    McLaurin, Eugene B.
    Narvekar, Abhijit
    Adewale, Adeniyi
    Gomes, Paul J.
    Torkildsen, Gail
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [34] Safety and efficacy comparison of emedastine 0.05% ophthalmic solution compared to levocabastine 0.05% ophthalmic suspension in pediatric subjects with allergic conjunctivitis
    Secchi, A
    Ciprandi, G
    Leonardi, A
    Deschenes, J
    Abelson, MB
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2000, 78 : 42 - 47
  • [35] The ocular efficacy and safety of 0.1% pemirolast potassium ophthalmic solution, a mast-cell stabilizer, in patients with seasonal allergic conjunctivitis
    Mundorf, TK
    Lonsdale, JD
    John, T
    Amdahl, LD
    Graves, AL
    Abelson, MB
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S770 - S770
  • [36] Evaluation of the efficacy and safety on allergic conjunctivitis of 0.001% Hydrocortisone-0.2% Hyaluronic Acid ophthalmic solution
    Allegri, P.
    Rissotto, R.
    Rissotto, F.
    Bergamino, L.
    Ciurlo, C.
    ALLERGY, 2020, 75 : 325 - 325
  • [37] SAFETY AND EFFICACY OF DICLOFENAC SODIUM 0.1-PERCENT OPHTHALMIC SOLUTION IN ACUTE SEASONAL ALLERGIC CONJUNCTIVITIS
    LAIBOVITZ, RA
    KOESTER, J
    SCHAICH, L
    REAVES, TA
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 1995, 11 (03) : 361 - 368
  • [38] Treatment of Chronic Allergic Conjunctivitis with Sustained Release Dexamethasone Using a Modified Conjunctival Allergen Challenge (Ora-CAC®) Model
    Mulani, Deepa
    McLaurin, Eugene B.
    Repke, Carolyn
    Sato, Michelle
    Gomes, Paul J.
    Ankerud, Eric
    Bassett, Michael
    Blizzard, Charles D.
    Driscoll, Arthur
    Sawhney, Amar
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [39] Efficacy and response with olopatadine versus epinastine in ocular allergic symptoms: A post hoc analysis of data from a conjunctival allergen challenge study
    Finegold, Ira
    Granet, David B.
    D'Arienzo, Peter A.
    Epstein, Arthur B.
    CLINICAL THERAPEUTICS, 2006, 28 (10) : 1630 - 1638
  • [40] Birch allergen challenges in allergic conjunctivitis using standard conjunctival allergen challenge and environmental exposure chamber
    Gherasim, Alina
    Fauquert, Jean-Luc
    Domis, Nathalie
    Siomboing, Xavier
    de Blay, Frederic
    CLINICAL AND TRANSLATIONAL ALLERGY, 2021, 11 (06)
12345